266 related articles for article (PubMed ID: 31963334)
1. Fibroblast Growth Factor 23-Producing Phosphaturic Mesenchymal Tumor with Extraordinary Morphology Causing Oncogenic Osteomalacia.
Then C; Asbach E; Bartsch H; Thon N; Betz C; Reincke M; Schmidmaier R
Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31963334
[TBL] [Abstract][Full Text] [Related]
2. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
3. Occult phosphaturic mesenchymal tumour of femur cortex causing oncogenic osteomalacia - diagnostic challenges and clinical outcomes.
Dutta D; Pandey RK; Gogoi R; Solanki N; Madan R; Mondal A; Dogra S; Thapa P
Endokrynol Pol; 2018; 69(2):205-210. PubMed ID: 29442350
[TBL] [Abstract][Full Text] [Related]
4. Reports of 17 Chinese patients with tumor-induced osteomalacia.
Yu WJ; He JW; Fu WZ; Wang C; Zhang ZL
J Bone Miner Metab; 2017 May; 35(3):298-307. PubMed ID: 27085966
[TBL] [Abstract][Full Text] [Related]
5. Persistent phosphaturic mesenchymal tumor causing tumor-induced osteomalacia treated with image-guided ablation.
Horng JC; Van Eperen E; Tutton S; Singh R; Shaker JL; Wooldridge AN
Osteoporos Int; 2021 Sep; 32(9):1895-1898. PubMed ID: 33655402
[TBL] [Abstract][Full Text] [Related]
6. Hypophosphataemia due to FGF-23 producing B cell non-Hodgkin's lymphoma.
Elderman JH; Wabbijn M; de Jongh F
BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27118742
[TBL] [Abstract][Full Text] [Related]
7. Tumor-induced osteomalacia originating from the temporal bone: a case report.
Kobayashi K; Nakao K; Kawai K; Ito K; Hukumoto S; Asakage T; Oota S; Motoi R
Head Neck; 2011 Jul; 33(7):1072-5. PubMed ID: 20146335
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic Osteomalacia From a Primary Phosphaturic Mesenchymal Tumor of the Toe: A Case Report.
Kim I; Rajani R
J Foot Ankle Surg; 2016; 55(2):294-8. PubMed ID: 25441266
[TBL] [Abstract][Full Text] [Related]
9. The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?
Ledford CK; Zelenski NA; Cardona DM; Brigman BE; Eward WC
Clin Orthop Relat Res; 2013 Nov; 471(11):3618-25. PubMed ID: 23868423
[TBL] [Abstract][Full Text] [Related]
10. [Tumor-induced osteomalacia caused by a late-revealing phosphaturic mesenchymal tumor].
Chazal T; Khanine V; Lidove O; Godot S; Ziza JM
Rev Med Interne; 2017 Jun; 38(6):412-415. PubMed ID: 27659744
[TBL] [Abstract][Full Text] [Related]
11. Tumor-induced osteomalacia: benign tumor recurrence after two surgical resections at two different medical institutions.
Yasuda S; Wada S; Kono S; Miyajima T; Oda H; Katayama S; Awata T
Endocr Pract; 2013; 19(4):e97-101. PubMed ID: 23512396
[TBL] [Abstract][Full Text] [Related]
12. Renal Phosphate Wasting Due to Tumor-Induced (Oncogenic) Osteomalacia.
Amaratunga EA; Ernst EB; Kamau J; Kotala R; Snyder R
Cureus; 2021 Jun; 13(6):e15507. PubMed ID: 34268038
[TBL] [Abstract][Full Text] [Related]
13. [Chronic progressive bone pain in an 82-year-old male patient].
Brückel J
Internist (Berl); 2021 Dec; 62(12):1343-1348. PubMed ID: 34652464
[TBL] [Abstract][Full Text] [Related]
14. Intracranial phosphaturic mesenchymal tumors: report of 2 cases.
Mathis DA; Stehel EJ; Beshay JE; Mickey BE; Folpe AL; Raisanen J
J Neurosurg; 2013 Apr; 118(4):903-7. PubMed ID: 23350780
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic osteomalacia due to phosphaturic mesenchymal tumour in the upper thoracic spine.
Garg B; Mehta N; Goyal A; Khadgawat R
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33328210
[TBL] [Abstract][Full Text] [Related]
16. Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma.
Slot-Steenks MM; Hamdy NA; van de Sande MA; Vriens D; Cleven AH; Appelman-Dijkstra NM
Endocrine; 2016 Dec; 54(3):642-647. PubMed ID: 27709474
[TBL] [Abstract][Full Text] [Related]
17. [Oncogenic osteomalacia: the role of the phosphatonins. Diagnostic usefulness of the Fibroblast Growth Factor 23 measurement in one patient].
Dupond JL; Magy N; Mahammedi M; Prie D; Gil H; Meaux-Ruault N; Kantelip B
Rev Med Interne; 2005 Mar; 26(3):238-41. PubMed ID: 15777586
[TBL] [Abstract][Full Text] [Related]
18. Ethmoid tumor and oncogenic osteomalacia: Case report and review of the literature.
Villepelet A; Casiraghi O; Temam S; Moya-Plana A
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Oct; 135(5):365-369. PubMed ID: 30026073
[TBL] [Abstract][Full Text] [Related]
19. Osteomalacia-Inducing Tumors of the Brain: A Case Report, Review and a Hypothesis.
Fathalla H; Cusimano M; Di Ieva A; Karamchandani J; Fung R; Kovacs K
World Neurosurg; 2015 Jul; 84(1):189.e1-5. PubMed ID: 25746588
[TBL] [Abstract][Full Text] [Related]
20. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]